(2R,3aR,11aS,12aR,14aR,Z)-N-(cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide, sodium salt
Simeprevir sodium is used as a potent, highly specific, and orally active inhibitor of hepatitis C virus (HCV) NS3/4A protease, effectively suppressing HCV replication; it also inhibits SARS-CoV-2 replication by targeting the viral main protease (Mpro) and RNA-dependent RNA polymerase (RdRp), modulates host immune responses, and exhibits synergistic antiviral activity with remdesivir.